This inventor holds 3 USPTO granted patents. Top assignee: Schering Aktiengesellschaft. Active years: 1999-2000.
Company Filing History:
Years Active: 1999-2000
Title: Jorg Elliesen: Innovator in Hormone Replacement Therapy
Introduction
Jorg Elliesen is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of hormone replacement therapy, holding a total of 3 patents. His work focuses on improving the administration and dosage of hormone therapies, which can greatly enhance patient compliance and treatment effectiveness.
Latest Patents
Elliesen's latest patents include a method and dispenser for hormone replacement therapy. This innovative approach allows for varying the daily dose of estrogen and progestogen without the need for a physician to prescribe a new product each time the dosage changes. The hormones are preferably administered transdermally from a dispenser that contains adjustable means for varying the volume of either or both compositions. This design facilitates optimal compliance with individually adjusted dosages, making hormone replacement therapy more accessible and manageable for patients.
Career Highlights
Jorg Elliesen is associated with Schering Aktiengesellschaft, a company known for its advancements in pharmaceuticals and healthcare. His work at Schering has allowed him to focus on developing innovative solutions in hormone therapy, contributing to the company's reputation as a leader in the field.
Collaborations
Elliesen collaborates with Jutta Riedl, a fellow innovator in the same field. Their partnership has fostered a productive environment for research and development, leading to advancements in hormone replacement therapies.
Conclusion
Jorg Elliesen's contributions to hormone replacement therapy through his patents and collaborations highlight his commitment to improving patient care. His innovative methods and devices are paving the way for more effective and personalized hormone treatments.